PRESERVATIVE FREE OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING TRAVOPROST AND TIMOLOL

• 1. 间苯二酚二邻苯二甲腈醚与双酚M二邻苯二甲腈醚和/或双酚T二邻苯二甲腈醚的树脂共混物 [P] . 中国专利： CN108884222A . 2018-11-23
• 2. 乳酸菌、发酵产物、邻苯三酚生产方法以及生产邻苯三酚的乳酸菌的筛选方法 [P] . 中国专利： CN107109355A . 2017-08-29
• 3. PRESERVATIVE FREE OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING TRAVOPROST AND TIMOLOL [P] . GR1008511B . 2015-06-05

  机译： 包含曲妥普洛和邻苯三酚的防腐剂，不含眼药的药物组合物

• 4. PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING BIMATOPROST AND TIMOLOL [P] . 美国专利： US2019076442A1 . 2019-03-14

  机译： 包含比马前列素和邻苯三酚的眼科药物的防腐剂

• 5. PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING BIMATOPROST AND TIMOLOL [P] . 欧洲知识产权局专利： EP3435974A1 . 2019-02-06

  机译： 包含比马前列素和邻苯三酚的眼科药物的防腐剂

• 1. A Three-Month, Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Compared to Travoprost 0.004% Ophthalmic Solution and Timolol 0.5% Dosed Concomitantly in Subjects With Open Angle Glauco [J] . Hughes BA, Craven ER, Mallick S, Journal of glaucoma . 2005,第5期
• 2. Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: A 12-week randomised controlled trial [J] . GoldbergI., GilPinaR., Lanzagorta-ArestiA., British journal of ophthalmology . 2014,第7期
• 3. A Phase III Randomized Clinical Trial of a 0.5% Timolol?+?0.2% Brimonidine?+?2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol?+?0.2% Brimonidine?+?2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma [J] . Francisco Gómez-Aguayo, José A. Paczka, Rubén Le?ero-Córdova, Ophthalmology and therapy. . 2018,第1期
• 4. Efficacy Analysis of Preservative-Free Tafluprost and Timolol in Open-Angle Glaucoma and OHT Patients in a Phase-III Study [C] . GrundenJ., Lupinacci R. International Symposium on Ocular Pharmacology and Therapeutics . 2013
• 5. Comparison of environmental impacts of wood treated with chromated copper arsenate (CCA) and three different arsenic-free preservatives. [D] . Dubey, Brajesh Kumar. 2005
• 6. Bimatoprost 0.03/timolol 0.5 preservative-free ophthalmic solution versus bimatoprost 0.03/timolol 0.5 ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial [O] . Ivan Goldberg, Rafael Gil Pina, Aitor Lanzagorta-Aresti, -1
• 7. Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma [O] . Joon Mo Kim, Tae-Woo Kim, Sang-Woo Park, 2021

• 1. Switching Study of Tafluprost/Timolol Fixed-Combination Ophthalmic Solution, Following Unfixed Combination of Tafluprost Ophthalmic Solution 0.0015 and Timolol Ophthalmic Gel-Forming Solution 0.5 [J] . Kazuhiro Matsumura ,Masayuki Kasahara ,Yoshiaki Ichibe . 眼科学期刊（英文） . 2019,第4期
• 2. Efficacy and Safety of Travoprost and Timolol Fixed Combination Compared to Travoprost in Patients with Primary Open Angle Glaucoma and Ocular Hypertension [J] . Gentian Hoxha ,Kelmend Spahiu ,Gazmend Kacaniku . 眼科学期刊（英文） . 2017,第3期
• 3. Comparative Evaluation of the Efficacy of the Bimatoprost 0.03, Brimonidine 0.2, Brinzolamide 1, Dorzolamide 2, and Travoprost 0.004/Timolol 0.5-Fixed Combinations in Patients Affected by Open-Angle Glaucoma [J] . Italo Giuffre . 眼科学期刊（英文） . 2012,第4期
• 4. Stripping Voltammetric Determination of Timolol Drug in Pharmaceuticals and Biological Fluids [J] . Ali F. Al-Ghamdi . 美国分析化学（英文） . 2011,第2期
• 5. Quick Single Run Capillary Zone Electrophoresis Determination of Active Ingredients and Preservatives in Pharmaceutical Products [J] . Marina Franco ,Renata Jasionowska . 美国分析化学（英文） . 2013,第3期
• 6. 邻苯三酚自氧化－化学发光法测超氧化物歧化酶（ＳＯＤ）活性：一种简便、快速、灵敏测定动植物体超氧化物歧 [C] . 郭蔼光 ,王振益 . 全国首届超氧化物歧化酶学术会议 . 1988
• 7. 邻苯三酚--三价铁离子络合修饰制备高导电粉体及其复合材料性能研究 [A] . 李雪 . 2019